Papers

7

Total Citations

127

H-Index

5

About

Hongzhao Li is a pioneering urological surgeon whose research focuses on advancing robot-assisted laparoscopic surgery, particularly in complex oncological and reconstructive procedures. His major contributions span telesurgery safety, neuroprotection during radical cystectomy, and comparative effectiveness of robotic versus laparoscopic partial nephrectomy for large renal tumors. Notably, his 2023 study on the safety and reliability of a robot-assisted telesurgery system (32 citations) expands the indications for urological surgery, while his 2015 work on dexmedetomidine’s neuroprotective effects (32 citations) provides critical insights into postoperative cognitive function. Li’s 2018 propensity score-based analysis (31 citations) demonstrates superior outcomes for robot-assisted partial nephrectomy over laparoscopy for tumors >4 cm. He also developed a modified sequential vascular control strategy for level III–IV inferior vena cava thrombectomy (23 citations), mimicking the open “milking” technique to reduce cardiopulmonary bypass time. His innovative “nerve-spring technique” for robotic intracorporeal Studer orthotopic neobladder achieves a functional trifecta outcome, enhancing continence and potency. With over 125 citations across his most-cited works, Li’s research is shaping the future of minimally invasive urological surgery.

Research Focus

Key Achievements

5
H-Index
7
Papers
127
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Safety and Reliability of a Robot-assisted Laparoscopic Telesurgery System: Expanding Indications in Urological Surgery
32 citations · 2023
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 49
🏛 Institutions: Chinese General Hospital College of Nursing and Liberal Arts, Chinese PLA General Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
    Robotic Adrenalectomy
    2 citations · 2020
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago